Next Article in Journal
Trust-Based Intelligent Routing Protocol with Q-Learning for Mission-Critical Wireless Sensor Networks
Next Article in Special Issue
Wearable Sensor Based on Flexible Sinusoidal Antenna for Strain Sensing Applications
Previous Article in Journal
A Chip Antenna for Bluetooth Earphones with Cross-Head Interference Tested from Received-Signal Sensing
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Microwave Ablation of Liver, Kidney and Lung Lesions: One-Month Response and Manufacturer’s Charts’ Reliability in Clinical Practice

IMAGINE UR UM 103, Department of Medical Imaging, Nîmes University Hospital, Montpellier University, 30029 Nîmes, France
*
Author to whom correspondence should be addressed.
Sensors 2022, 22(11), 3973; https://doi.org/10.3390/s22113973
Submission received: 21 April 2022 / Revised: 16 May 2022 / Accepted: 19 May 2022 / Published: 24 May 2022
(This article belongs to the Special Issue Microwave and Antenna System in Medical Applications)

Abstract

Microwave ablation systems allow for performing tumoral destruction in oncology. The objective of this study was to assess the early response and reliability of the microwave ablation zone size at one month for liver, kidney and lung lesions, as compared to the manufacturer’s charts. Patients who underwent microwave ablation with the EmprintTM ablation system for liver, kidney and lung lesions between June 2016 and June 2018 were retrospectively reviewed. Local response and ablation zone size (major, L, and minor, l, axes) were evaluated on the one-month follow-up imaging. Results were compared to the manufacturers’ charts using the Bland–Altman analysis. Fifty-five patients (mean age 68 ± 11 years; 95 lesions) were included. The one-month complete response was 94%. Liver ablations showed a good agreement with subtle, smaller ablation zones (L: −2 ± 5.7 mm; l: −5.2 ± 5.6 mm). Kidney ablations showed a moderate agreement with larger ablations for L (L: 8.69 ± 7.94 mm; l: 0.36 ± 4.77 mm). Lung ablations showed a moderate agreement, with smaller ablations for l (L: −5.45 ± 4.5 mm; l: −9.32 ± 4.72 mm). With 94% of early complete responses, the system showed reliable ablations for liver lesions, but larger ablations for kidney lesions, and smaller for lung lesions.
Keywords: interventional radiology; percutaneous ablation; tumour response; microwave; oncology interventional radiology; percutaneous ablation; tumour response; microwave; oncology

Share and Cite

MDPI and ACS Style

Frandon, J.; Akessoul, P.; Kammoun, T.; Dabli, D.; de Forges, H.; Beregi, J.-P.; Greffier, J. Microwave Ablation of Liver, Kidney and Lung Lesions: One-Month Response and Manufacturer’s Charts’ Reliability in Clinical Practice. Sensors 2022, 22, 3973. https://doi.org/10.3390/s22113973

AMA Style

Frandon J, Akessoul P, Kammoun T, Dabli D, de Forges H, Beregi J-P, Greffier J. Microwave Ablation of Liver, Kidney and Lung Lesions: One-Month Response and Manufacturer’s Charts’ Reliability in Clinical Practice. Sensors. 2022; 22(11):3973. https://doi.org/10.3390/s22113973

Chicago/Turabian Style

Frandon, Julien, Philippe Akessoul, Tarek Kammoun, Djamel Dabli, Hélène de Forges, Jean-Paul Beregi, and Joël Greffier. 2022. "Microwave Ablation of Liver, Kidney and Lung Lesions: One-Month Response and Manufacturer’s Charts’ Reliability in Clinical Practice" Sensors 22, no. 11: 3973. https://doi.org/10.3390/s22113973

APA Style

Frandon, J., Akessoul, P., Kammoun, T., Dabli, D., de Forges, H., Beregi, J.-P., & Greffier, J. (2022). Microwave Ablation of Liver, Kidney and Lung Lesions: One-Month Response and Manufacturer’s Charts’ Reliability in Clinical Practice. Sensors, 22(11), 3973. https://doi.org/10.3390/s22113973

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop